Halman A

Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

8 papers · 2 preprints · ORCID

ArticlePsychedelics

Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development.

Halman A, Corriden R

Europe PMC2026
ArticleDMT

Acute experiences and persisting psychological effects associated with an encapsulated DMT-harmala alkaloid combination: results of a phase 1 study.

Perkins D, Halman A, Urokohara A +7

Europe PMC2025
ArticleAyahuasca

Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.

Pagni BA, Halman A, Sarris J +3

Europe PMC2026
ArticleAyahuasca

Associations Between Ayahuasca Use in Naturalistic Settings and Mental Health and Wellbeing Outcomes: Analysis of a Large Global Dataset.

Perkins D, Sarris J, Cowley-Court T +7

Europe PMC2026
ArticlePsilocybin

Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.

Halman A, Conyers R, Moore C +3

Europe PMC2025
ArticlePsilocybin

Artificial intelligence and psychedelic medicine.

Sarris J, Halman A, Urokohara A +2

Europe PMC2024
ArticlePsilocybin

Drug-drug interactions involving classic psychedelics: A systematic review.

Halman A, Kong G, Sarris J +1

Europe PMC2024
ArticleAyahuasca

Ayahuasca: A review of historical, pharmacological, and therapeutic aspects.

Ruffell SGD, Crosland-Wood M, Palmer R +13

Europe PMC2023
PreprintPsilocybin

Drug-drug interactions between classic psychedelics and psychoactive drugs: a systematic review

Halman A, Kong G, Sarris J +1

Europe PMC2023
PreprintAyahuasca

Ayahuasca – a review of historical, pharmacological, and therapeutic aspects

Ruffell S, Netzband N, Tsang W +9

Europe PMC2023